STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G

MPHGBX Schedule 13G filing by Bank of America

Bank of America reported beneficial ownership of 41.0M shares, representing 5.1% of MEREO BIOPHARMA GROUP PLC in this filing.

FiledMay 14, 2026
Ownership dateMar 31, 2026
Reported shares41.0M
Reported ownership5.1%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 0
Shared voting power 41.0M
Sole dispositive power 0
Shared dispositive power 41.0M
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
Bank of America
CIK
CIK0000070858
Accession
0000070858-26-000293
Form
Schedule 13G
Open SEC filing View MPHGBX ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →